Where can I buy shares of ZSAN?
Shares of ZSAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is zosano Pharma (ZSAN) a good buy?
Zosano Pharma (ZSAN) Gets a Buy Rating from Maxim Group. Maxim Group analyst Anthony Vendetti maintained a Buy rating on Zosano Pharma (ZSAN) yesterday and set a price target of $8.
Is zosano Pharma efficiently growing its dividend?
Zosano Pharma does not have a long track record of dividend growth. In the past three months, Zosano Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,000.00 in company stock.
What is zosano Pharma's net margin and return on equity?
Zosano Pharma had a negative net margin of 3,367.90% and a negative trailing twelve-month return on equity of 75.96%. View Zosano Pharma's earnings history.
Is ZSAN a good stock to buy?
Zosano Pharma Corp (NASDAQ:ZSAN) The 1 analysts offering 12-month price forecasts for Zosano Pharma Corp have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +2,525.00% increase from the last price of 0.80.
Will ZSAN get FDA approval?
The shot recently gained FDA authorization for the age group, and CDC advisors are expected to give it their nod of approval. Studies have shown that two doses provide virtually no barrier against omicron variant infection in children aged 5 to 11, so the extra jab might boost immunity.
What does zosano Pharma do?
Zosano Pharma is a clinical-stage biopharmaceutical company enabling the systemic administration of therapeutics and other bioactive molecules to patients using our proprietary transdermal microneedle patch system.
Why did Zosano stock drop?
Fremont, CA-based Zosano ($ZSAN) delivered bitter news to its investors on Monday evening, tipping off the market that Eli Lilly ($LLY) had bowed out of their osteoporosis partnership while it had also decided to halt work on a daily dosing program.
What is Qtrypta?
Qtrypta is an intracutaneous patch—about the size of a quarter—that uses drug-coated microneedles to deliver the well-established migraine med zolmitriptan to the bloodstream.
What is AXS 07?
AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic investigational medicine for the acute treatment of migraine, consisting of MoSEIC™ meloxicam and rizatriptan.
What is microneedle array patch?
A microneedle array patch (MAP) has been developed as a new delivery system for vaccines. Preclinical and clinical trials with a vaccine MAP showed improved stability, safety, and immunological efficacy compared to conventional vaccine administration. Various vaccines can be delivered with a MAP.
Is Zosano Pharma a buy right now?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zosano Pharma in the last year. There are currently 2 ho...
When is Zosano Pharma's next earnings date?
Zosano Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022. View our earnings forecast for Zosano...
How were Zosano Pharma's earnings last quarter?
Zosano Pharma Co. (NASDAQ:ZSAN) announced its quarterly earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) EPS for t...
When did Zosano Pharma's stock split? How did Zosano Pharma's stock split work?
Shares of Zosano Pharma reverse split on Tuesday, April 12th 2022. The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of...
What price target have analysts set for ZSAN?
3 equities research analysts have issued 12-month target prices for Zosano Pharma's shares. Their forecasts range from $70.00 to $70.00. On average...
Who are Zosano Pharma's key executives?
Zosano Pharma's management team includes the following people: Mr. Steven Lo , Sr. VP of Operations, Pres, CEO & Director (Age 55, Pay $534.08k)...
Who are some of Zosano Pharma's key competitors?
Some companies that are related to Zosano Pharma include Oragenics (OGEN) , Oragenics (OGEN) , Aileron Therapeutics (ALRN) , PhaseBio Pharmaceu...
What other stocks do shareholders of Zosano Pharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS...
When did Zosano Pharma IPO?
(ZSAN) raised $47 million in an initial public offering (IPO) on Tuesday, January 27th 2015. The company issued 4,300,000 shares at $10.00-$12.00 p...
When will Zosano's first quarter end?
Is Zosano a biopharmaceutical?
FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2021, as well as business highlights.
ZSAN: Proposed Public Offering
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article titled, “Long Term Safety, Tolerability, and Efficacy of Intracutaneous Zolmitriptan (M207) in the Acute Treatment of Migraine” was published in The Journal of Headache and Pain.
Publication of Clinical Data
On Tuesday, the company announced the initiation of an underwritten public offering. The offering will comprise of units having ZSAN’s common stock shares along with warrants to buy its common stock, sold by the company.
ZSAN: Board Changes
On January 05, the company announced the publication of its Phase 1 clinical trial data in the Journal of Vaccines and Immunology. The data was published in an article by the name “Immunogenicity and Safety of Inactivated Influenza Split-Virion Vaccine Administered via a Transdermal Microneedle System”.
Why are Analyst Ratings Important?
On December 13, ZSAN announced some changes to its Board of Directors. Firstly, Elaine M. Yang was appointed to Board. Ms. Yang currently serves as the Chief Revenue Officer at Lyra Health Inc. Before this, she has also served at executive positions with Facebook as well as Genetech.
What's Happening With Zosano Pharma Corp Stock Today?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices.
